Benzonatate
- Product NDC
- 68071-2562
- 11-digit product format
- 680712562
- Labeler code
- 68071
- Product ID
- 68071-2562_235c6dec-d33c-929e-e063-6394a90a57ad
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Benzonatate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA211518
- Marketing category
- ANDA
- Marketing start
- 2019-02-22
- Substance
- BENZONATATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 5P4DHS6ENR | BENZONATATE | 104-31-4 | BENZONATATE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68071-2562-2 | 68071256202 | 21 CAPSULE in 1 BOTTLE (68071-2562-2) | 21 capsule | 2024-09-30 | No | No | Historical |
| 68071-2562-3 | 68071256203 | 30 CAPSULE in 1 BOTTLE (68071-2562-3) | 30 capsule | 2021-11-02 | No | No | Historical |